We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter
Est. Return
+23.44%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$90.5B
AUM Growth
+$5.41B
(+6.4%)
Cap. Flow
-$1.73B
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
20.12%
Holding
5,141
New
939
Increased
1,573
Reduced
1,769
Closed
818
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$732M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$553M |
| 3 |
Applied Materials
AMAT
|
+$327M |
| 4 |
Intuit
INTU
|
+$320M |
| 5 |
Chevron
CVX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$651M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$298M |
| 5 |
Qualcomm
QCOM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.2% |
| 2 | Technology | 14.41% |
| 3 | Healthcare | 5.76% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Phathom Pharmaceuticals
PHAT
$769M
| $343K | ﹤0.01% |
31,595
-243,566
| -89% | -$2.78M |
|
3677
PUT
TE Connectivity
TEL
$60.4B
| $343K | ﹤0.01% |
1,700
-11,500
| -87% | -$2.45M |
|
3678
Alamo Group
ALG
$2.11B
| $343K | ﹤0.01% |
+2,083
| New | +$337K |
|
3679
iShares MSCI Poland ETF
EPOL
$862M
| $342K | ﹤0.01% |
+8,860
| New | +$348K |
|
|
LTC
3680
LTC Properties
LTC
$2.22B
| $342K | ﹤0.01% |
8,893
-22,636
| -72% | -$860K |
|
3681
Brown-Forman Class A
BF.A
$12.4B
| $342K | ﹤0.01% |
+12,482
| New | +$343K |
|
3682
4D Molecular Therapeutics
FDMT
$827M
| $340K | ﹤0.01% |
25,576
-36,937
| -59% | -$360K |
|
3683
Cognex
CGNX
$10.5B
| $340K | ﹤0.01% |
4,693
-116,497
| -96% | -$7.07M |
|
|
NTST
3684
NETSTREIT Corp
NTST
$2.04B
| $340K | ﹤0.01% |
16,076
-248,382
| -94% | -$5.03M |
|
3685
PUT
NextDecade
NEXT
$1.95B
| $339K | ﹤0.01% |
+45,000
| New | +$356K |
|
3686
Alkami Technology
ALKT
$2.11B
| $339K | ﹤0.01% |
18,715
-31,261
| -63% | -$516K |
|
3687
Corporacion America
CAAP
$3.99B
| $339K | ﹤0.01% |
13,467
-12,018
| -47% | -$309K |
|
3688
Mirum Pharmaceuticals
MIRM
$6.15B
| $339K | ﹤0.01% |
2,896
-58,796
| -95% | -$5.9M |
|
3689
iRadimed
IRMD
$1.07B
| $339K | ﹤0.01% |
3,546
-843
| -19% | -$76.8K |
|
3690
PUT
iShares MSCI Mexico ETF
EWW
$1.8B
| $339K | ﹤0.01% |
4,500
-22,200
| -83% | -$1.72M |
|
|
CLYM
3691
Climb Bio
CLYM
$891M
| $338K | ﹤0.01% |
25,956
-17,018
| -40% | -$176K |
|
3692
Neuropace
NPCE
$511M
| $338K | ﹤0.01% |
21,265
-8,671
| -29% | -$140K |
|
3693
Vitesse Energy
VTS
$749M
| $338K | ﹤0.01% |
21,418
+4,326
| +25% | +$76.6K |
|
3694
Arcturus Therapeutics
ARCT
$450M
| $338K | ﹤0.01% |
50,253
+36,479
| +265% | +$288K |
|
3695
CNB Financial Corp
CCNE
$1.03B
| $337K | ﹤0.01% |
+9,999
| New | +$311K |
|
3696
Park National Corp
PRK
$3.52B
| $335K | ﹤0.01% |
1,832
-544
| -23% | -$94K |
|
3697
Fennec Pharmaceuticals
FENC
$434M
| $335K | ﹤0.01% |
31,132
-25,378
| -45% | -$207K |
|
3698
Keros Therapeutics
KROS
$224M
| $334K | ﹤0.01% |
+31,204
| New | +$348K |
|
3699
PUT
Global Payments
GPN
$24.5B
| $334K | ﹤0.01% |
4,600
+800
| +21% | +$55.1K |
|
3700
PUT
Equifax
EFX
$20.8B
| $333K | ﹤0.01% |
2,100
+500
| +31% | +$85.2K |
|
Similar funds
VM
Squarepoint's Q2 2026 Portfolio in Review
As of Q2 2026, Squarepoint held 5,141 positions worth $90.5B, up 6.4% from $85.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Squarepoint's Q2 2026 filing shows 939 new, 1,573 increased, 1,769 reduced and 818 closed positions. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M. The largest sale was iShares Core S&P 500 ETF, an estimated $3.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
- Squarepoint's largest Q2 2026 buy was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $732M increase.
- Squarepoint's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.03B.
- Squarepoint fully exited VanEck Semiconductor ETF in Q2 2026, selling an estimated $192M.
- Squarepoint's ten largest holdings make up 20% of its $90.5B portfolio in Q2 2026.
- Squarepoint opened 939 new positions and closed 818 in Q2 2026.
- Squarepoint's portfolio value rose 6.4% quarter-over-quarter to $90.5B.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.